Last updated on December 2018

Open-Label Extension and Safety Study of Talazoparib


Brief description of study

This is a single-arm, open-label, extended treatment, safety study in patients treated with talazoparib in qualifying studies.

Clinical Study Identifier: NCT02921919

Contact Investigators or Research Sites near you

Start Over

Pfizer Pfizer CT.gov Call Center

UCLA Hematology/Oncology - Santa Clarita
Valencia, CA United States
4.11miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.